C157H170N24O17 — CID 160922911
1-[1-[2-(azetidin-1-yl)ethyl]indazol-5-yl]-4-(4-cyclopropylphenoxy)-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-(3-hydroxy-3-methylazetidin-1-yl)ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-[(3R)-3-hydroxypyrrolidin-1-yl]ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-(3-methoxyazetidin-1-yl)ethyl]indazol-5-yl]-2H-pyrrol-5-one (PubChem CID 160922911) has the molecular formula C157H170N24O17 and a molecular weight of 2665.24 g/mol. Its IUPAC name is 1-[1-[2-(azetidin-1-yl)ethyl]indazol-5-yl]-4-(4-cyclopropylphenoxy)-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-(3-hydroxy-3-methylazetidin-1-yl)ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-[(3R)-3-hydroxypyrrolidin-1-yl]ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-(3-methoxyazetidin-1-yl)ethyl]indazol-5-yl]-2H-pyrrol-5-one.
| Compound Name | 1-[1-[2-(azetidin-1-yl)ethyl]indazol-5-yl]-4-(4-cyclopropylphenoxy)-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-(3-hydroxy-3-methylazetidin-1-yl)ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-[(3R)-3-hydroxypyrrolidin-1-yl]ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-(3-methoxyazetidin-1-yl)ethyl]indazol-5-yl]-2H-pyrrol-5-one |
|---|---|
| PubChem CID | 160922911 |
| Molecular Formula | C157H170N24O17 |
| Molecular Weight | 2665.24 g/mol |
| Exact Mass | 2663.32 |
| IUPAC Name | 1-[1-[2-(azetidin-1-yl)ethyl]indazol-5-yl]-4-(4-cyclopropylphenoxy)-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-(3-hydroxy-3-methylazetidin-1-yl)ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-[(3R)-3-hydroxypyrrolidin-1-yl]ethyl]indazol-5-yl]-2H-pyrrol-5-one;4-(4-cyclopropylphenoxy)-1-[1-[2-(3-methoxyazetidin-1-yl)ethyl]indazol-5-yl]-2H-pyrrol-5-one |
| SMILES | CC1(O)CN(CCn2ncc3cc(N4CC=C(Oc5ccc(C6CC6)cc5)C4=O)ccc32)C1.COC1CN(CCn2ncc3cc(N4CC=C(Oc5ccc(C6CC6)cc5)C4=O)ccc32)C1.O=C1C(Oc2ccc(C3CC3)cc2)=CCN1c1ccc2c(cnn2CCN2CCC2)c1.O=C1C(Oc2ccc(C3CC3)cc2)=CCN1c1ccc2c(cnn2CCN2CCC[C@@H]2CO)c1.O=C1C(Oc2ccc(C3CC3)cc2)=CCN1c1ccc2c(cnn2CCN2CCC[C@H]2CO)c1.O=C1C(Oc2ccc(C3CC3)cc2)=CCN1c1ccc2c(cnn2CCN2CC[C@@H](O)C2)c1 |
| InChI | InChI=1S/2C27H30N4O3.3C26H28N4O3.C25H26N4O2/c2*32-18-23-2-1-12-29(23)14-15-31-25-10-7-22(16-21(25)17-28-31)30-13-11-26(27(30)33)34-24-8-5-20(6-9-24)19-3-4-19;1-32-23-16-28(17-23)12-13-30-24-9-6-21(14-20(24)15-27-30)29-11-10-25(26(29)31)33-22-7-4-19(5-8-22)18-2-3-18;1-26(32)16-28(17-26)12-13-30-23-9-6-21(14-20(23)15-27-30)29-11-10-24(25(29)31)33-22-7-4-19(5-8-22)18-2-3-18;31-22-9-11-28(17-22)13-14-30-24-8-5-21(15-20(24)16-27-30)29-12-10-25(26(29)32)33-23-6-3-19(4-7-23)18-1-2-18;30-25-24(31-22-7-4-19(5-8-22)18-2-3-18)10-13-28(25)21-6-9-23-20(16-21)17-26-29(23)15-14-27-11-1-12-27/h2*5-11,16-17,19,23,32H,1-4,12-15,18H2;4-10,14-15,18,23H,2-3,11-13,16-17H2,1H3;4-10,14-15,18,32H,2-3,11-13,16-17H2,1H3;3-8,10,15-16,18,22,31H,1-2,9,11-14,17H2;4-10,16-18H,1-3,11-15H2/t2*23-;;;22-;/m10..1./s1 |
| InChIKey | SSGMTKLCWIJPGN-ZHHMJAMISA-N |
| XLogP | 21.42 |
| TPSA | 393.75 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 45 |
| Heavy Atoms | 198 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2665.24 |
| LogP ≤ 5 | 21.42 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 35 |